Table 2.

Correlations analysis of variables with circulating ANGPTL8 levels in control subjects with normal glucose tolerance (NGT), and T2DM patients with A1, A2, and A3.

	Control subjects with NGT		Type 2 diabetic patients
			A1		A2		A3
	r	p	r	p	r	p	r	p
Age	0.001	0.994	0.139	0.167	0.046	0.766	0.023	0.898
BMI	−0.002	0.988	−0.112	0.268	0.101	0.508	0.309	0.080
SBPa	0.134	0.370	−0.111	0.280	−0.013	0.937	0.168	0.374
DBPa	0.146	0.327	−0.106	0.303	0.011	0.943	0.085	0.654
TGa	0.158	0.288	0.191	0.061	0.379	0.013	0.381	0.038
TCa	0.127	0.396	0.019	0.855	0.197	0.210	0.007	0.971
LDL-Ca	−0.050	0.740	−0.030	0.768	0.116	0.465	0.150	0.430
HDL-Ca	−0.078	0.602	0.068	0.510	0.179	0.257	−0.095	0.618
Fasting plasma glucosea	−0.142	0.342	0.049	0.635	0.228	0.147	−0.160	0.398
Fasting insulina	−0.119	0.426	−0.098	0.337	0.193	0.221	0.001	0.995
HOMA-IRa	−0.154	0.300	−0.101	0.327	0.260	0.096	−0.073	0.702
HbA1ca	−0.040	0.792	0.151	0.140	0.079	0.619	0.149	0.431
Duration of diabetesa	–	–	0.246	0.015	0.390	0.011	0.431	0.017
eGFR	0.156	0.294	−0.116	0.256	−0.374	0.015	−0.435	0.016
Urinary ACR	0.111	0.458	0.160	0.118	0.538	<0.001	0.502	0.005

^aP-value determined by partial correlation analysis (age, sex, and BMI adjusted).